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Abstract
Non-healing and partially healing wounds are an important problem not only for the patient but
also for the public health care system. Current treatment solutions are far from optimal regarding
the chosen material properties as well as price and source. Biodegradable polyurethane (PUR)
scaffolds have shown great promise for in vivo tissue engineering approaches, but
accomplishment of the goal of scaffold degradation and new tissue formation developing in
parallel has not been observed so far in skin wound repair. In this study, the mechanical
properties and degradation behavior as well as the biocompatibility of a low-cost synthetic,
pathogen-free, biocompatible and biodegradable extracellular matrix mimicking a PUR scaffold
was evaluated in vitro. The novel PUR scaffolds were found to meet all the requirements for
optimal scaffolds and wound dressings. These three-dimensional scaffolds are soft, highly
porous, and form-stable and can be easily cut into any shape desired. All the material
formulations investigated were found to be nontoxic. One formulation was able to be deﬁned
that supported both good ﬁbroblast cell attachment and cell proliferation to colonize the scaffold.
Tunable biodegradation velocity of the materials could be observed, and the results additionally
indicated that calcium plays a crucial role in PUR degradation. Our results suggest that the PUR
materials evaluated in this study are promising candidates for next-generation wound treatment
systems and support the concept of using foam scaffolds for improved in vivo tissue engineering
and regeneration.
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1. Introduction
Badly healing and non-healing wounds are problematic not
only for the individual patient but also for society at large
because extensive and repeated treatment inﬂicts very high
costs on the public health care system [1]. Therefore, not only
is prompt closure of skin wounds of great importance for
good patient care, but the demand for inexpensive and
effective treatments for badly healing and non-healing
wounds is of enormous curative, social, and industrial
interest.
Skin wounds can have a different etiology, including
physical (e.g., prolonged compression resulting in bedsores) or
thermal injury as well as the presence of underlying medical or
physiological conditions (e.g., diabetes). Accordingly, they can
be roughly classiﬁed into acute and chronic wounds. Whereas
acute wounds usually heal completely within a reasonable time
frame of up to six weeks, chronic wounds take very long to
heal and often never really close or re-occur [2]. Different
chronic wounds have individual characteristics. The prognosis
for complete closure depends on a patient’s health status,
wound type (i.e., venous versus non-venous), wound size,
vascularization, microbiological status, and, especially with
diabetic wounds, patient compliance.
Generally, the healing of acute wounds encompasses the
phases of inﬂammation, proliferation (encompassing granu-
lation and epithelialization), and remodeling/maturation, with
the latter phases being dominated by the formation and
remodeling of the extracellular matrix (ECM). When any one
of the steps in this process is compromised, wound healing
can stagnate, which usually results in ECM degradation [3–5].
The ECM is, however of crucial importance for tissue
regeneration because it serves as a matrix for the ingrowth of
cells into the wound [6].
Commonly used wound care dressing materials include
ﬁlms, hydrogels, hydroﬁbers, and foams, with each class
having distinct advantages and disadvantages [7]. However,
current wound treatment concepts as well as products are
based mainly on the application of natural or artiﬁcial scaf-
folds to mimic the structural environment of the intact human
dermis [8, 9]. These scaffolds include but are not limited to a
range of dermal matrices [10] and alginate dressings [11] as
well as materials and composites such as chitosan/PLA [12],
PVA/alginate [13], cellulose/collagen [14], and silk [15].
Despite the progress that has been made with artiﬁcial dres-
sings, most of the commercially available cell adhesion–
promoting scaffolds contain collagen [9], which has the
potential to transmit pathogens or to elicit hypersensitivity
[16]. In addition, wound care based on the application of such
scaffolds is usually very expensive [7]. Due to their good
biocompatibility, polyurethanes (PURs) have been of great
interest in the medical ﬁeld in recent years; this has ultimately
led to the introduction of biodegradable PU scaffolds [17–21].
However, a slow degradation velocity (>several weeks to
months for complete degradation) of these scaffolds limits
their potential use for the treatment of skin wounds. The
mechanisms for increased degradation are rather unknown
[22], and therefore, the goal of parallel scaffold degradation
and new tissue formation has not been able to be achieved
to date.
To design a novel wound dressing that matches the
challenging criteria of a degradable scaffold for in vivo tissue
engineering, many issues need to be solved. First and fore-
most, the raw materials need to be inexpensive and available
from various sources, and they must be biocompatible and
biodegradable according to International Organisation for
Standardisation (ISO) standards 10993-5 and 10993-13. In
the case of a polyurethane scaffold, polyurethane being a
heterogenic polymer, this is especially difﬁcult because all
ingredients, including the monomers, pre-polymers, organic
and metal–organic catalysts, and reaction products, must meet
these requirements. From an analytical point of view, in
contrast with some predictable leachables, the in vitro
degradation and identiﬁcation of toxicologically relevant
degradation products of a polyurethane matrix under various
conditions cannot be easily monitored, identiﬁed, or even
fully covered by standard chemical methods. An additional
drawback is that the currently used ISO standard 10993-13
falls short in terms of development of meaningful degradation
studies.
The aim of this study was to evaluate an in vivo tissue
engineering wound treatment concept based on a completely
synthetic biodegradable PUR scaffold that is expected to
serve as an artiﬁcial non-cytotoxic ECM to support wound
healing by facilitating cell adhesion and ingrowth. A second
aim was to deﬁne one or more factors affecting the biode-
gradation of the scaffold in the wound in order to be able to
steer its degradation rate by modiﬁcation of the production
process and the ratios between the various components.
Figure 1 depicts the series of events envisioned during wound
repair supported by the new biodegradable PUR scaffold.
Characterization of the PUR scaffolds showed that the overall
pore structure is independent, whereas the degradation rate
and cell adhesion are greatly dependent, on the exact for-
mulation of the material. Furthermore, it was found that cal-
cium ions were affecting the degradation rate. The evaluated
set of materials was found to be, irrespective of the for-
mulation, not toxic; and in evaluating the adhesion of single
cells as well as the outgrowth from clustered cell spheroids, a
PUR formulation could be identiﬁed that shows good cell
adhesion and cell ingrowth. In conclusion, the studied PUR
scaffolds showed great promise for supporting wound heal-
ing, thus warranting additional in vivo studies.
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2. Materials and methods
2.1. Characterization of PUR scaffolds
For qualitative evaluation of the scaffold structure, scanning
electron microscopy (SEM) was employed. For this, a 10 nm-
thick layer of gold was applied (Polaron Equipment, SEM
Coating Unit E5100, Kontron AG, Switzerland; 5 mA,
1 mbar, 10 min; 10 nm-thick coating) on the PUR scaffolds,
and the samples were imaged at 30x magniﬁcation with a
Hitachi S-4800 scanning electron microscope (Hitachi High-
Technologies, Canada) at an accelerating voltage of 10 kV
and with 10 μA current ﬂow.
For quantitative evaluation of different structural indices
of the PUR scaffolds, a high-resolution microcomputed x-ray
system (μCT 40, Scanco Medical, Brüttisellen, Switzerland)
without the addition of a contrasting agent was chosen. The
specimens were scanned at an energy of 45 kV and an
intensity of 176 μA. An integration time of 300 ms and two-
times averaging were used to enhance the signal-to-noise ratio
because of the low adsorption coefﬁcient of the PUR. Two-
dimensional CT images were scanned and reconstructed in
2048 × 2048 pixel matrices from 1,000 projections using a
standard convolution–backprojection procedure. Images were
stored in 3D arrays with an isotropic voxel size of 6 μm. After
the images were pre-processed with the same Gaussian ﬁlter
to partially suppress the noise, the gray-value images were
segmented with different threshold values to extract the foam
or the aggregate matrix. Structural indices of the foams were
computed and determined using a computer analysis method.
The structural parameters reported are porosity (%), average
macropore size (μm), and average wall thickness (μm).
2.2. Degradability and mechanical properties of PUR scaffolds
The degradation experiments were carried out according to ISO
10993-13:2009-08. The specimens (3× 3× 0.5 cm3) were
incubated in H2O2 at 37 °C (1 g: 10ml) to mimic the oxidative
degradation occurring in the wound. The peroxide solution was
changed every 3–4 days to maintain a constant degradation
milieu. The specimens were dried in a desiccator over P2O5
until reaching weight constancy before and after degradation
assay to determine weight loss. The specimens were separated
from the peroxide solution by centrifugation using a PALL
Macrosep Advance 0.2 μm Supor Membrane at 3,900 rpm.
Mechanical tests were performed as described previously
[23], with the following modiﬁcations: compression tests with
2 × 3 × 4 cm blocks and elasticity tests with 2 × 1 × 0.8 cm
membranes in triplicate with 5% strain/min on an Instron
5567 setup from Instron Corporation, UK.
2.3. High-performance liquid chromatography–mass
spectrometry
For the high-performance liquid chromatography–mass
spectrometry (HPLC-MS), the foam was incubated in water
or culture media overnight at 37 °C. The supernatants were
then analyzed using an RP18 column as the stationary phase
(Phenomenex Gemini 250 × 2 mm; 5 μm) on an Agilent 1100
series system with a diode array detector coupled to an
esquire HCT ion trap mass spectrometer (Bruker, Germany)
equipped with an electrospray ionization (ESI) source and
operated in the positive mode. An isocratic elution was car-
ried out at a ﬂow rate of 0.5 ml min−1 using acetonitrile/water
10% (v/v) containing 0.1% (v/v) formic acid; the 2,2-
dimorpholinodiethylether (DMDEE) was determined to be
Figure 1. The in vivo tissue engineering based wound treatment concept. The series of events envisioned during wound repair supported by
the biodegradable PUR scaffold. Upon wetting, the PUR scaffold adapts to the wound bed, allowing cells to easily migrate into the scaffold.
The scaffold is degraded and blood vessels form until the material is completely replaced by newly formed tissue, eventually leading to a
healed wound.
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m/z 244.9 [M+H]+ (calculated exact mass 244.18 g mol−1;
extracted ion current chromatogram mass processed with
HyStar). The mass spectra were veriﬁed by using the
DMDEE raw material as the external and internal standard.
The important ionization parameters were chosen as follows:
dry temperature: 360 °C, HV capillary: 4600 V, nebulizer:
40 psi, dry gas: 8.0 l min.−1 ICP-OES measurements of the
aqueous foam extracts revealed a concentration of Bi ions
lower than 0.5 ppm (using an ICP-OES Optima 3000, Perkin
Elmer). Thus, the foam samples were treated according to a
standard procedure [23] with nitric acid plus sonication and
were subsequently diluted in water to a deﬁned volume.
Optical analysis was carried out at the emission of Bi at
223.061 and 306.766 nm.
2.4. Material extracts and pre-incubated PUR scaffolds
Material extracts were prepared according ISO10993-5/12.
Brieﬂy, PUR scaffolds were cut into discs of 20 mm and
placed in six-well plates and 2.1 ml culture medium (Dul-
becco’s modiﬁed eagle medium (DMEM) supplemented with
10% fetal calf serum (FCS); 2 mM of L-glutamine and 5%
penicillin/streptomycin (pen/strep)) were added. Following
24 h incubation at 37 °C with 5% CO2, the extracts were used
for 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) and protein assays and HPLC-MS (culture
medium without FCS and pen/strep), whereas the PUR
scaffolds were used for cell adhesion and colonization assays.
2.5. MTT and protein assays
The effect of material extracts on cellular activity was
assessed by an MTT assay as described previously [24]. In
brief, 24 h after seeding at a density of 10 000 cells per 96-
well plate well, 3T3 ﬁbroblast cultures (ECACC 85022108,
Sigma) were treated for 24 h by a control medium or material
extracts. Subsequently, the cells were washed once with plain
DMEM before the addition of 25 μl of an MTT solution
(5 mg ml−1) to each well for 1 h at 37 °C. The solution was
then removed, and intracellular MTT–formazan crystals were
dissolved in 90% (v/v) ethanol for 10 min. Absorbance was
measured at 550 nm, and wells without cells were used as
blanks. For measurement of the inﬂuence of material extracts
on total protein content as an index of total cell mass, a
bicinchoninic acid (BCA) protein assay (Pierce Nr. 23225;
Thermo Fisher Scientiﬁc, USA) was employed. In brief, the
medium was removed and the cells were washed twice with
phosphate buffered saline (PBS, pH 7.4) prior to the addition
of 200 μl of BCA solution (1:50 reagent A:B) in a rotary
shaker for 1 h at room temperature (RT). Absorbance was
measured at 550 nm, wells without cells were used as blanks,
and serial dilutions of bovine serum albumin were used as the
standard.
2.6. Fibroblast cell adhesion on and colonization of PUR
scaffolds
Pre-incubated PUR scaffolds were placed in six-well plates,
and 2.1 ml of culture medium was added. Sterilized 10 mm
glass rings were placed on top to keep the scaffolds sub-
mersed, and 3 × 105 mouse 3T3 ﬁbroblasts were seeded on
top of the scaffolds. Alternatively, cell spheroids consisting of
1.5 × 104 human dermal ﬁbroblasts (HDFs, expanded in the
laboratory from a biopsy of adult abdominal skin as described
previously [25]) were formed by centrifugation for 5 min at
200 rpm and subsequent culture in polypropylene tubes for
24 h before the spheroids were transferred to on top of the
PUR scaffolds. The culture medium was changed after 24 h
and every 2–3 days thereafter. On indicated days, the cells
were ﬁxed with 4% paraformaldehyde (PFA)/0.2% Triton X-
100 (TX-100) for 8 min and stored in PBS until staining.
2.7. Immunohistochemistry
For immunohistochemical staining of cells cultivated on the
PUR scaffolds, antibodies/dyes were diluted in PBS and
incubation steps were performed at RT for 1 h. Actin and the
nuclei were stained using Alexa546 conjugated phalloidin
(1:40, Molecular Probes, B607) and DAPI (4,6-diamidino-2-
phenylindole, 1:1000, Sigma–Aldrich, D9542), respectively.
Samples were washed extensively with PBS before imaging
on a confocal laser scanning microscope (LSM780, Zeiss,
Oberkochen, Germany). Due to the 3D nature of the scaf-
folds, the images were acquired in z-stacks and presented as
maximum-intensity projections.
2.8. Live/dead viability assay
Mouse ﬁbroblasts (3T3) cultivated for 1 and 4 days on PUR
scaffolds were evaluated with a live/dead viability kit (Invi-
trogen, L3224) according to the manufacturer’s instructions
with minor modiﬁcations. In brief, the culture medium was
removed and the cells were cultivated in a fresh medium
supplemented with 1.3 μM ethidium homodimer-1 and
2.6 μM calcein AM for 10 min at 37 °C. Subsequently, the
cells were washed with fresh culture medium and imaged on a
confocal laser scanning microscope equipped with an incu-
bator set to 37 °C. Control samples of dead cells were pro-
duced by treatment of cells with 0.2% digitonin in PBS for
5 min prior to incubation with dyes.
2.9. Statistical analysis
Statistical analysis was performed using Student’s t-test. The
results shown are triplicate measurements (mean ± SD, SD=
standard deviation) obtained from at least three independent
experiments.
3. Results
3.1. PUR-scaffold structure is independent of the exact
formulation
To evaluate the structure and homogeneity of the PUR scaffolds,
the samples were analyzed by scanning electron microscopy
(SEM) and μ-computed tomography (μCT) (ﬁgure 2). SEM-
image analysis revealed similar pore sizes and pore size
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distributions for all formulations, which was conﬁrmed by the
μCT. Structural parameters were computed from the obtained
CT scans, showing porosity values of 68–77%, pore thickness of
100–150 μm, and wall thickness of 35–51 μm (table 1(a)). Pore
size and wall thickness distributions are displayed in ﬁgure s1.
The mechanical properties of the scaffolds were
evaluated by compression tests in both the dry and the wet
state. Depending on the formulation, different compression
hardnesses could be observed. It is interesting that,
although scaffold D showed intermediate hardness in the
dry state, wetting resulted in only a 19% reduction in
hardness. In contrast, the hardness of the other scaffolds
was reduced by 43–73% as result of wetting (table 1(b)).
When the samples were wetted, their diameters increased
by 10% (scaffold D) to 35% (scaffold A) within the ﬁrst
30 min and remained constant for the rest of the observed
period of time (ﬁgure 3). The height of the samples
tended to increase over this time period. This increase
was, however, within the limitations of the measurements
(data not shown). Notably, the sample diameter of the
reference material Promogran shrank by 22% over the
course of 3 h. Furthermore, the thickness of the Promogran
greatly decreased (by approximately 15–20%), indicating
that its porous structure collapsed upon wetting (data not
shown).
Figure 2. Characteristics of PUR scaffolds. PUR scaffolds A, B, C, and D were imaged by scanning electron microscopy (SEM) or
μ-computed tomography (μCT) with corresponding measurements shown in table 1(a) (scale bar 1 mm).
Figure 3. Swelling of PUR scaffolds. PUR scaffolds were immersed
in PBS for 30, 60, 120, 240, and 360 min before the diameter was
measured (20 mm at t= 0; n= 2, mean ± SD).
Table 1. Characteristics of PUR scaffolds. Data are expressed as mean ± SD (a) porosity values (n = 2), (b) compression hardness at RT
(n= 5–6) and 37 °C/90% relative humidity (r.h.; n = 5–6).
Scaffold A Scaffold B Scaffold C Scaffold D
(a) Porosity (%) 78 ± 2 76 ± 1 73 ± 2 68 ± 1
Pore size (μM) 150 ± 19 114 ± 5 136 ± 12 104 ± 18
Wall thickness (μM) 43 ± 1 36 ± 3 52 ± 1 48 ± 6
(b) Compression hardness (kPa) RT/dry 73 41 26 38
37 °C/90% r.h 20 22 15 30
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3.2. PUR-scaffolds display formulation-dependent degradation
rates
The degradability of the PUR scaffolds was assessed by
incubating the samples in 20% H2O2 for up to two weeks with
subsequent measurement of the mass loss. When the PUR
scaffolds were incubated in 20% (v/v) H2O2, scaffold A
showed a degradation of 37%, 86%, and 95% by days 1, 7,
and 14, respectively (ﬁgure 4). Scaffolds B and C, in contrast,
showed only little degradation by day 3, with values reaching
36% and 40% by day 14. Sample D displayed an even slower
degradation, reaching 10% by day 7 and 22% by day 14. The
reference material Promogran showed a degradation pattern
similar to that of scaffold A. Like scaffold A, it was com-
pletely degraded by day 14. In contrast with the other eval-
uated materials, the scaffold structure of Promogran had
collapsed by day 1. The second reference material, Monocryl,
showed almost no degradation after 14 days. Of interest is
that the oxidative degradation rate was greatly affected by the
presence and concentration of calcium ions (ﬁgure 5). In
evaluating scaffold A, almost no degradation could be
observed with 3% H2O2 on days 3 and 7. However, the
addition of CaCl2 increased the degradation rate in a con-
centration-dependent manner (ﬁgure 5(a)). Similar degrada-
tion behavior was found when using 10% instead of 3% H2O2
(ﬁgure 5(b)).
3.3. Leachable concentrations of PUR scaffolds are not toxic
To evaluate whether non-crosslinked components are released
at toxic concentrations from the PUR scaffolds, PUR scaffold
extracts were subjected to HPLC-MS before assessment of
cytotoxicity by measuring MTT conversion as an index of
metabolic activity and total protein content. As only the
leachable polyurethane catalyst DMDEE (ﬁgure s2) could be
detected via HPLC-MS (data not shown) and when exposing
3T3 mouse ﬁbroblasts for 24 h with the 24 h extracts, only a
9–25% reduction in total protein content as well as a 14–34%
reduction in metabolic activity could be observed (ﬁgure 6).
Of importance is that none of the values were signiﬁcantly
below 70% of the control values, which, according the
ISO10993-5 standard, is seen as an acceptable reduction
threshold. This suggests that none of the materials release
acute cytotoxic constituents. Also, the protein and metabolic
activity values of the individual scaffolds were not sig-
niﬁcantly different from one another.
3.4. Cell adhesion, but not viability, is dependent on the
formulation of the PUR scaffolds
The ability of the cells to adhere to the PUR scaffolds was
assessed by cultivating 3T3 mouse ﬁbroblasts for 24 h and
96 h on the samples (ﬁgure 7). To visualize the cells on the
scaffold, the cells were stained thereafter for the actin
cytoskeleton and the nuclei. After 24 h, the cells formed
clusters on scaffolds A through C but showed good attach-
ment to and spreading on scaffold D. Similar behavior could
be seen after 96 h, with cell clusters on scaffolds A and C,
indicating improved attachment and spreading but not
reaching the degree of spreading observed on scaffold D.
To evaluate a possible adverse effect of PUR scaffolds on
cells contacting the scaffold, a live/dead assay was performed
(ﬁgure 7). The cell clusters formed on scaffolds A through C
displayed bright green staining (living cells) and only a few
red-stained dots (dead cells). Similarly, the well-spread cells
on scaffold D were mostly bright green with, however,
slightly more cells showing red-stained nuclei compared with
the other scaffolds. Overall, this clearly shows good viability
of cells cultivated on PUR scaffolds.
3.5. Cells show good ingrowth into PUR scaffold D
With scaffold D allowing very good cell attachment and
spreading, the ability of cells to grow into the scaffold was
tested by cultivating clustered cell spheroids consisting of
1.5 × 104 human dermal ﬁbroblasts (HDFs) on PUR scaffolds
for 24 h, 5 days, and 10 days (ﬁgure 8). Thereafter, the actin
cytoskeleton and the nuclei were stained to visualize the cells.
The cell spheroids showed good attachment after 24 h, and
single HDFs grew out into the scaffold by day 5. Robust
outgrowth from the spheroid and migration of the cells into
the scaffold could be observed after 10 days, with single cells
showing good cell attachment and spreading.
4. Discussion
In the present study a set of new polyurethane foams as
possible scaffold candidates for skin substitutes were
characterized.
Based on the premise of an optimal wound dressing, the
ideal scaffold should have the following characteristics [26]:
(i) three-dimensional and highly porous, with an inter-
connected pore network for cell/tissue growth and ﬂow
transport of nutrients and metabolic waste; (ii) easily able to
be processed to form a variety of shapes and sizes; (iii) sui-
table surface chemistry for cell attachment, proliferation, and
differentiation without eliciting an inﬂammatory or allergic
Figure 4. Degradability of PUR scaffolds. PUR scaffolds were
submersed in 20% H2O2 and incubated for 1, 4, 7, and 14 days
before the extent of degradation was assessed. Promogran and
Monocryl served as fast and non-degrading control materials,
respectively. (n = 2; each data point represents the mean of triplicate
measurements.)
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response; (iv) biodegradable or bioresorbable, with a con-
trollable degradation and resorption rate to match cell/tissue
growth in vitro and/or in vivo; (v) mechanical properties to
match those of the tissues at the site of implantation. Fur-
thermore, protection from bacterial invasion is seen as addi-
tional ideal characteristic [8].
Our currently developed set of materials exhibited char-
acteristics which, depending on the composition, meet all or
nearly all of these requirements:
(i) and (ii) Scaffold morphology and processing. The
evaluated scaffolds are soft wound surface adaptable and can
be simply cut with knives or scissors in any desired shape
before application. Injectable PUR scaffolds offer more
ﬂexibility in terms of tissue repair [27, 28] and better adapt-
ability to the wound bed in the case of the skin [29]. How-
ever, it can be expected that access to the foam-shaped
scaffolds described herein from the tissue side is improved
due to the high porosity with deﬁned partially interconnected
pores, which are shape stable for several days. Of importance
is that during production, pore size and pore size distribution
can be inﬂuenced by altering the processing parameters, e.g.,
pressure (data not shown), which allows for even further
optimization of the scaffold structure. Overall, this proves that
the PUR material can be easily processed as three dimen-
sional and highly porous with an interconnected pore network
for cell/tissue growth and ﬂow transport of nutrients and
metabolic waste.
(iii) Cell attachment. The ﬁbroblast cells displayed good
attachment to the surface of the materials, which was espe-
cially apparent in the case of scaffold D, where excellent
adhesion of a single cell layer could be observed. Further-
more, simulating tissue ingrowth with clustered cell spheroids
showed that cells were able to colonize the obviously non-
toxic materials. The cyto-compatibility of the materials was
further demonstrated by a live/dead assay showing excellent
cell viability. This is in good agreement with previous studies
of biodegradable PUR scaffolds showing good cyto-compat-
ibility [30, 31]. Evaluation of PUR scaffold extracts showed
only minor, insigniﬁcant reduction of cell metabolic activity
and protein content—observations similar to previous studies
[31, 32]. Thus, our data gives clear evidence that the PUR
material is not toxic and exhibits suitable surface chemistry
for cell attachment, proliferation, and differentiation.
(iv) Degradation. It was found that the degradation
velocity of the scaffolds was dependent on various factors,
i.e., the degradation method used, the composition of the
degradation medium, and the composition of the scaffold
material. In PBS and water, no degradation could be observed
by day 28 (data not shown). This is in good agreement with
previous studies of biodegradable polyurethane scaffolds,
which showed only little to no degradation after four weeks in
PBS [17, 20, 30, 33]. However, when using hydrogen per-
oxide solutions to test for oxidative degradation of the PUR
scaffolds, the materials showed that degradation rates very
much depended on the exact formulation, being tunable from
Figure 5. Inﬂuence of CaCl2 on the degradation rate of PUR scaffold A. PUR scaffold A was submersed in (a) 3% H2O2 or (b) 10% H2O2,
both supplemented with 0, 1.31, 2.62, or 5.24 mM CaCl2 and incubated for 3 and 7 days before the extent of degradation was assessed (n= 4,
mean of duplicate measurements).
Figure 6. Toxicity of PUR-scaffold extracts. PUR-scaffold extracts
obtained by submersing the samples in a medium for 24 h were
added to 3T3 mouse ﬁbroblasts for 24 h, and metabolic activity (via
MTT) and total protein content were evaluated. A concentration
series of CdSO4 served as the negative control. (n = 7, mean ± SD;
*: p < 0.05 different from control. #: p < 0.05 signiﬁcant below 70%
value).
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as little at 20% to complete degradation within 14 days. Of
interest is that the degradation rates were greatly inﬂuenced
by the presence and concentration of the divalent metal cation
calcium. Incubated at a physiological concentration of 3%
H2O2, the PUR scaffolds showed no degradation by day 7.
However, when adding 5.24 mM CaCl2 to the solution, a
mass loss of 50% could be observed under otherwise identical
conditions. It is interesting that accelerated degradation could
not be observed upon supplementation with either magnesium
or iron (data not shown). Such an auto-oxidative effect of
speciﬁc metals has long been known [34] and has been
exploited to study the biostability of PUR materials [35]. The
positive inﬂuence of calcium on PUR scaffold degradation is
especially interesting since, dependent on the skin layer, a
gradient from 0.5 to 1.4 mM of calcium can be found in
mammalian skin [36]. Furthermore, these levels have been
shown to increase up to ﬁvefold during skin wound healing
[37], which may facilitate PUR scaffold degradation in vivo.
Preliminary results in rats support this hypothesis, with
complete degradation being observed after several days to a
few weeks (data not shown). Chronic wounds, on the other
hand, can have a deregulated balance of trace metal con-
centrations [38], and thus, availability of calcium for an
accelerated degradation of the PUR scaffold may be limited in
such an environment. This can probably be compensated by
wetting the PUR scaffold using a calcium-containing Ringer
solution with 2.2 mM Ca2+ prior to or just after application,
which has the further advantage that calcium has a recognized
positive effect on wound healing [36]. Therefore, our data
clearly show that the PUR material is biodegradable or
Figure 7. Cell adhesion and viability of scaffold cultivation on PUR scaffolds in vitro. Pre-incubated (24 h) PUR scaffolds were seeded with
3 × 105 3T3 mouse ﬁbroblasts for 24 h (d1) and 96 h (d4) before staining for actin (red) and nuclei (blue) or ethidium homodimer-1 (red) and
calcein AM (green), respectively (scale bar 100 μm).
Figure 8. Cell ingrowth into PUR scaffold D from spheroid cultures in vitro. Pre-incubated (24 h) PUR scaffolds were seeded with cell
spheroids consisting of 1.5 × 104 human dermal ﬁbroblasts (HDFs) for 24 h, 5 days, and 10 days before staining for actin (red) and nuclei
(blue, scale bar 100 μm).
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bioresorbable, with a controllable degradation and resorption
rate to match cell/tissue growth in vitro and, as preliminary
data show, also in vivo (publication in preparation).
(v) Mechanical properties. A further interesting char-
acteristic of the tested materials is their swelling property
upon wetting. Thereby, good adaptability and ﬁrm contact
with the wound bed can be achieved. This is in contrast with
the reference material Promogran, which, while demonstrat-
ing good performance in vivo [39], collapsed upon wetting.
Swelling is, however, also beneﬁcial for the wound healing
process, as it builds a small amount of pressure on wound
boundaries. This may increase the contact with this tissue and
decrease wound contraction and, as a result, stimulate cell
ingrowth and likely wound healing. Furthermore, although
the tested PUR scaffolds are ﬂexible, they are form-stable for
days, and it can thus be expected that they, in contrast with,
e.g., collagen matrices, will withstand the contractile forces
generated by cells. This resilience might give the materials
tested herein a critical advantage over less form-stable scaf-
folds, as it will likely hamper the formation of myoﬁbroblasts
as recently shown in in vivo experiments using these scaffolds
(publication in preparation), which facilitate scar formation
during wound healing [40]. These data provide evidence that
the PUR material has, besides being biocompatible, optimal
mechanical properties matching those needed for the skin to
support wound healing.
(vi) Infections. All chronic wounds are in a persistent
pro-inﬂammatory state that is multifactorial related to local
tissue hypoxia, necrosis, and a heavy bacterial burden that
delays or hinders healing by impaired cell migration and
reduced ﬁbroblast proliferation and collagen synthesis [41].
However, equipping or soaking the PUR scaffolds from this
study with antimicrobial substances (e.g., ionic silver, mole-
cular iodine, activated carbon, sulfonamide, or poly-
hexamethyl biguanide) that provide continuous or sustained
release of these agents may potentially alleviate this problem.
5. Conclusions
In conclusion, the PUR scaffolds tested present a wound
dressing concept that fulﬁlls the key criteria for an optimal
scaffold for tissue engineering and thereby provide a material
that has the potential to meet the requirements for an ideal
wound dressing. This has been supported by very promising
preliminary results in rats but has yet to be fully evaluated
before translation into clinics.
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